<?xml version="1.0" encoding="UTF-8"?>
<p>The CHIKV outbreaks in Asia, the Indian Ocean islands and its recent introduction to the Americas and the Caribbean made clear the ability of arthritogenic alphaviruses to rapidly spread and cause epidemics on a global scale. This has been fueled by genomic mutations favoring virus ecological fit to new mosquito vectors
 <xref rid="imr12825-bib-0068" ref-type="ref">68</xref>, 
 <xref rid="imr12825-bib-0069" ref-type="ref">69</xref>, 
 <xref rid="imr12825-bib-0070" ref-type="ref">70</xref>, 
 <xref rid="imr12825-bib-0071" ref-type="ref">71</xref> and an exponential increase in international travelers to and from developing economies.
 <xref rid="imr12825-bib-0012" ref-type="ref">12</xref>, 
 <xref rid="imr12825-bib-0072" ref-type="ref">72</xref>, 
 <xref rid="imr12825-bib-0073" ref-type="ref">73</xref>, 
 <xref rid="imr12825-bib-0074" ref-type="ref">74</xref>, 
 <xref rid="imr12825-bib-0075" ref-type="ref">75</xref> Importantly, the expansion of CHIKV distribution and the establishment of local transmission hotspots in newly colonized areas pose a high risk of co‐infections with other highly prevalent tropical diseases. A number of epidemiological studies have reported co‐infections of CHIKV with pathogens such as Zika virus (ZIKV), dengue virus (DENV), and malaria parasites in humans
 <xref rid="imr12825-bib-0076" ref-type="ref">76</xref>, 
 <xref rid="imr12825-bib-0077" ref-type="ref">77</xref>, 
 <xref rid="imr12825-bib-0078" ref-type="ref">78</xref>, 
 <xref rid="imr12825-bib-0079" ref-type="ref">79</xref>, 
 <xref rid="imr12825-bib-0080" ref-type="ref">80</xref>, 
 <xref rid="imr12825-bib-0081" ref-type="ref">81</xref>, 
 <xref rid="imr12825-bib-0082" ref-type="ref">82</xref>, 
 <xref rid="imr12825-bib-0083" ref-type="ref">83</xref>, 
 <xref rid="imr12825-bib-0084" ref-type="ref">84</xref>, 
 <xref rid="imr12825-bib-0085" ref-type="ref">85</xref> although the pathological outcomes of these co‐infections have not been clearly defined. Particularly, different clinical reports from African malaria cohorts
 <xref rid="imr12825-bib-0086" ref-type="ref">86</xref>, 
 <xref rid="imr12825-bib-0087" ref-type="ref">87</xref>, 
 <xref rid="imr12825-bib-0088" ref-type="ref">88</xref>, 
 <xref rid="imr12825-bib-0089" ref-type="ref">89</xref> suggested the presence of CHIKV infections. Furthermore, the highly pro‐inflammatory profiles of both diseases—including the detrimental contribution of T cell‐mediated immune responses to the pathologies—and the immunosuppressive nature of malaria infections speculate that immune modulation might occur.
</p>
